Recruiting
Retrospective Analyses of TrakStar Database
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
ClinicalTrials.gov IDNCT06917339
PhaseNot Applicable
Enrollment156000
SponsorNeuronetics
Age5 Years
SexALL
Conditions studied
Depression, Obsessive-Compulsive Disorder, Anxiety Depression
About this study
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Interventions
- Device: NeuroStar Advanced TMS Therapy System — non-invasive brain stimulation device
Primary outcomes
- Change in clinical assessment score from baseline to post-treatment (8 weeks)
Eligibility information
Inclusion Criteria:
* Male or female reported in database and not an invalid entry
* Age reported and not an invalid entry
* Treatment date of November 01, 2008 or later.
Exclusion Criteria:
• Incomplete information on treatment parameters
Study locations
- Neuronetics, Malvern, Pennsylvania 19355 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.